Characteristics | Patient |
---|---|
Age | 59 years |
Gender | Male |
Height | 186 cm |
Body weight | 90 kg |
Cancer type | Metastatic, hormone-refractory, poorly-differentiated prostate adenocarcinoma |
Gleason score | 8 (4 + 4) |
Metastases | Residual primary tumor within the prostate bed with bilateral seminal vesicle infiltration and multiple lymph node as well as bone metastases |
Stage of the disease (at initial diagnosis) | IV |
Karnofsky index (at the time of this study) | 90% |
Relevant previous surgery | Cytoreductive Da-Vinci assisted robotic prostatovesiculectomy with bilateral regional lymphadenectomy |
Other relevant treatment | Androgen deprivation therapy with NSAA (Bicalutamide) and GnRH analogue (Leuprorelin, Trenantone™) |
PET/CT scan (152Tb-PSMA-617) | 24 Days after PET/CT scan with 68Ga-PSMA-11 |